Biobank Cohort Forum
New methods for analysing circulating tumour DNA (ctDNA) in blood samples are under development. These methods have attracted great commercial and clinical interest for early tumour detection but highlight a gap in biobanking practices today: While most biobanking is moving towards smaller and smaller volumes, analysis of ctDNA typically requires 8-12 ml of plasma. Ensuring […]
